MetabolomicsWorkbenchapplication/xmlhttp://www.metabolomicsworkbench.org/rest/study/study_id/ST000523/mwtabprimaryOK200Mass SpectrometryESIEnvironmental Exposurehttp://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST000523Gender:POOL_BATCH1 | Timing of Sample Collection:POOL_BATCH1 | Type of Family Member:POOL_BATCH1Gender:Female | Timing of Sample Collection:term (birth) | Type of Family Member:childGender:Male | Timing of Sample Collection:term (birth) | Type of Family Member:childGender:LIPIDOMICS_STD | Timing of Sample Collection:LIPIDOMICS_STD | Type of Family Member:LIPIDOMICS_STDGender:Female | Timing of Sample Collection:1st trimester | Type of Family Member:motherGender:CHEAR_REFERENCE | Timing of Sample Collection:CHEAR_REFERENCE | Type of Family Member:CHEAR_REFERENCEGender:POOL_BATCH2 | Timing of Sample Collection:POOL_BATCH2 | Type of Family Member:POOL_BATCH2Gender:RED_CROSS_REFERENCE | Timing of Sample Collection:RED_CROSS_REFERENCE | Type of Family Member:RED_CROSS_REFERENCEGender:Female | Timing of Sample Collection:term (birth) | Type of Family Member:motherGender:POOL_BATCH3 | Timing of Sample Collection:POOL_BATCH3 | Type of Family Member:POOL_BATCH3BloodPOSITIVE ION MODE. NEGATIVE ION MODE. POSITIVE ION MODE/Lipids. NEGATIVE ION MODE/Lipids.MetabolomicsWorkbenchMetabolomicsHomo SapiensUniversity of MichiganPC 36:5; [M-Ac-H]-TG 40:0; [M+NH4]+TG 42:0; [M+NH4]+SM 37:0; [M]+lysoPE 16:0; [M+H]+SALICYLATE #2 (M-H)-plasmenyl-PE 38:5; [M+H]+FFA(18:0)plasmenyl-PC 44:4; [M+Na]+PE 36:2; [M+H]+LAURIC ACID (M-H)-SM 40:1; [M]+CE(18:1); [M+NH4]+CL 66:1; [M-2H](2-)GLYCOCHENODEOXYCHOLIC ACID (M+H)+[-H2O]INOSINE (M+H)+DG 38:5; [M+NH4]+PE 38:5; [M+H]+DIPALMITOYL PHOSPHATIDYLETHANOLAMINE (M-H)-THYROXINE (M+Cl)-SM 36:2; [M+Na]+SM 42:2; [M]+FFA(18:1)plasmenyl-PE 40:4; [M+H]+L-TRYPTOPHAN-15N2 [ISTD] (M-H)-SM 34:1; [M+Na]+plasmenyl-PE 34:3; [M-H]-TG 52:3; [M+Na]+PI 34:2; [M-H]-PC 34:2; [M+Na]+plasmenyl-PE 32:0; [M-H]-THYROXINE (M-H)-N-CYCLOHEXYLFORMAMIDE (M+Na)+PE 37:4; [M-H]-TG 52:0; [M+NH4]+GLUCARIC ACID (M-H)-TG 51:0; [M+NH4]+TG 53:0; [M+NH4]+lysoPE 18:0; [M+H]+SM 39:1; [M+Na]+P-ACETAMIDOPHENYL BETA-D-GLUCURONIDE (2M-H)-URIDINE (M-H)-1-METHYLXANTHINE (M+Na)+ARACHIDONIC ACID (M-H)-VALINE (M+Na)+GLUCOSE (M+Cl)-lysoPC 18:0; [M+H]+TG 54:0; [M+NH4]+TG 60:9; [M+NH4]+BIS(2-ETHYLHEXYL)PHTHALIC ACID (M+H)+PC 40:4; [M-Ac-H]-PC 42:10; [M-Ac-H]-plasmenyl-PE 36:5; [M+H]+IS d5-DAGETHYLMALONIC ACID (M-H)-IS PG 34:0 ; [M-H]-PC 30:1; [M+Na]+OLEIC ACID (M+H)+TG 50:0; [M+NH4]+PC 38:4; [M+Na]+PE 30:0; [M-H]-DG 40:5; [M+NH4]+5-AMINOPENTANOIC ACID (M+H)+HOMOGENTISIC ACID (M+H)+PC 33:0; [M-Ac-H]-SM 41:2; [M+Na]+SM 45:2; [M]+ZEATIN [ISTD] (M+H)+plasmenyl-PE 36:2; [M+H]+3-HYDROXY-3-METHYLGLUTARIC ACID (M-H)-PC 37:3; [M-Ac-H]-TETRADECADIENOYLCARNITINE (*) M+PHENYLALANINE (M-H)-PC 33:2; [M-Ac-H]-PE 39:4; [M-H]-plasmenyl-PE 34:0; [M-H]-EDTA (M+H)+lysoPC 20:4; [M+Na]+INOSINE (M+Cl)-PE 36:3; [M-H]-SM 32:1; [M+Na]+EPIBRASSINOLIDE [ISTD] (M+Na)+TG 50:2; [M+NH4]+PC 38:5; [M-Ac-H]-PE 40:5; [M-H]-PE 38:2; [M-H]-plasmenyl-PE 38:6; [M-H]-TG 52:2; [M+NH4]+PC 32:2; [M+Na]+5-HYDROXYTRYPTOPHAN (M-H)-PE 39:6; [M+H]+PHYTANIC ACID (M-H)-1-METHYLADENOSINE (M+Cl)-LINOLEOYLCARNITINE (*) (M+H)+PC 38:5; [M+H]+plasmenyl-PE 40:5; [M-H]-IS lysoPC 17:0; [M+H]+CAFFEINE (M+H)+lysoPE 22:6; [M-H]-CE(16:1); [M+NH4]+PC 36:6; [M+H]+HOMOVANILLIC ACID (2M-H)-TG 48:1; [M+Na]+CITRIC ACID (M-H)-DG 32:3; [M+NH4]+DG 34:3; [M+NH4]+PC 34:3; [M+Na]+PC 28:1; [M-Ac-H]-TG 58:2; [M+NH4]+LYSINE (M-H)-S-HEXYL-GLUTATHIONE (M+H)+CITRAMALIC ACID (M-H)-16:0 LYSO PC (M+H)+TG 48:2; [M+NH4]+TG 56:2; [M+NH4]+SM 34:2; [M+Na]+lysoPC 20:5; [M+H]+PC 42:10; [M+H]+TG 46:2; [M+NH4]+URIC ACID (M+Na)+DG 36:3; [M+NH4]+DG 40:7; [M+NH4]+TG 54:2; [M+NH4]+METHIONINE (M+H)+lysoPC 16:0; [M+H]+TG 44:2; [M+NH4]+CALCIDIOL (M+H)+[-H2O]lysoPE 16:0; [M-H]-TG 54:7; [M+NH4]+TG 58:7; [M+NH4]+SM 35:2; [M]+PG 36:2; [M-H]-DEHYDROEPIANDROSTERONE SULFATE (M-H)-PE 40:7; [M+H]+2-HYDROXY-4-(METHYLTHIO)BUTYRIC ACID (M-H)-FFA(16:0)lysoPC 18:2; [M+Na]+CE(17:1); [M+NH4]+SM 32:1; [M]+EICOSANOYLCARNITINE (*) (M+H)+PE 33:2; [M-H]-PE 40:8; [M-H]-plasmenyl-PE 38:3; [M-H]-plasmenyl-PC 36:4; [M+Na]+PE 38:5; [M-H]-SM 38:4; [M]+HIPPURIC ACID (M+Na)+PE 36:5; [M+H]+PI 38:5; [M-H]-N-ACETYL-L-PHENYLALANINE (M-H)-PE 35:1; [M-H]-plasmenyl-PE 38:2; [M+H]+PE 35:4; [M-H]-ISOLEUCINE (M+Na)+lysoPC 20:3; [M+Na]+3-HYDROXYLAUROYLCARNITINE (*) (M+H)+PC 38:3; [M-Ac-H]-THEOBROMINE (M+Na)+PC 32:0; [M-Ac-H]-PE 32:0; [M-H]-GLYCEROL MYRISTATE (M+Na)+N-ACETYL-DL-SERINE (M+H)+[-H2O]IS PS 34:0 ; [M-H]-SM 42:4; [M]+lysoPE 22:5; [M+H]+PC 32:2; [M-Ac-H]-ADENOSINE 5'-MONOPHOSPHATE (M+H)+TG 51:4; [M+NH4]+TG 53:4; [M+NH4]+1,7-DIMETHYL URIC ACID (M-H)-CHOLESTEROL (M+H)+[-H2O]TG 49:0; [M+NH4]+1-METHYLADENOSINE (M+H)+16:0-18:0 PC (M+Cl)-IS PC 34:0; [M-Ac-H]-METHYL JASMONATE (M+Na)+TG 56:7; [M+NH4]+SM 38:2; [M+Na]+PC 32:3; [M+H]+S-ADENOSYL-L-HOMOCYSTEINE (M-H)-PG 36:3; [M-H]-GLUCOSE (M+Na)+TG 56:5; [M+NH4]+IS PI 37:4 ; [M-H]-lysoPC 18:1; [M+H]+3-METHOXYTYROSINE (M+H)+lysoPC 20:0; [M+H]+TG 52:5; [M+NH4]+TG 53:5; [M+NH4]+3-(4-HYDROXYPHENYL)LACTIC ACID (M+H)+HYODEOXYCHOLIC ACID (M-H)-SM 42:5; [M]+IS PE 34:0; [M+H]+lysoPC 18:3; [M+Na]+OXALIC ACID (M-H)-PE 36:5; [M-H]-OCTENOYLCARNITINE (*) M+OLEIC ACID (M-H)-IS PE 34:0 ; [M-H]-TG 50:1; [M+Na]+KYNURENIC ACID (M-H)-TG 56:6; [M+NH4]+CE(20:5); [M+NH4]+EDTA (M+Na)+CE(16:0); [M+NH4]+GLUTARYLCARNITINE (*) (M+H)+plasmenyl-PE 36:2; [M-H]-TG 52:6; [M+NH4]+ZEATIN [ISTD] (M-H)-lysoPC 17:1; [M+H]+PG 34:0; [M-H]-SM 38:1; [M]+ISOCITRIC ACID (M-H)-PC 39:6; [M-Ac-H]-PC 38:6; [M-Ac-H]-PHENYLALANINE (M+H)+BILIVERDIN (M+H)+N-METHYL-GLUTAMIC ACID (M+Na)+PI 36:1; [M-H]-N-ACETYL-D-TRYPTOPHAN (M-H)-L-[15N]ANTHRANILIC ACID [ISTD] (M-H)-DG 33:0; [M+NH4]+N-(octadecanoyl)-sphing-4-enine; [M-H]-DG 32:0; [M+NH4]+GLYCOCHENODEOXYCHOLIC ACID (M+H)+lysoPC 16:1; [M+H]+N-ACETYLGLYCINE (M-H)-PE 36:3; [M+H]+PI 40:6; [M-H]-SM 38:0; [M]+1,3,7-TRIMETHYLURIC ACID (M-H)-URIDINE (M+Cl)-PG 33:0; [M-H]-1-METHYLXANTHINE (M+H)+lysoPE 18:1; [M-H]-ACETAMINOPHEN (TN TYLENOL) (M-H)-ARACHIDONATE #2 (M-H)-P-ACETAMIDOPHENYL BETA-D-GLUCURONIDE (M+Na)+3-DEHYDROXYCARNITINE (M+H)+STEAROYLCARNITINE (*) (M+H)+THEOPHYLLINE (M+H)+PC 32:3; [M+Na]+TG 52:3; [M+NH4]+TG 56:3; [M+NH4]+PC 38:7; [M+Na]+INOSINE (M-H)-lysoPE 18:0; [M+Na]+DG 32:1; [M+NH4]+PE 38:3; [M-H]-lysoPC 22:6; [M+H]+SM 41:2; [M]+AHBA (M+H)+SM 42:2; [M+Na]+plasmenyl-PE 42:5; [M-H]-plasmenyl-PC 18:0; [M+Na]+DG 36:1; [M+NH4]+SM 40:4; [M]+GLUTAMINE (M-H)-MEVALONIC ACID (M-H)-BIS(2-ETHYLHEXYL)PHTHALIC ACID (M+Na)+DG 33:1; [M+NH4]+OLEIC ACID (M+Na)+L-TRYPTOPHAN-15N2 [ISTD] (M+H)+IS TG 51:0; [M+NH4]+HIPPURIC ACID (M+H)+PANTOTHENIC ACID (M+Na)+PE 32:2; [M-H]-GERANYLGERANYL DIPHOSPHATE (M-H)-PC 37:2; [M-Ac-H]-PE 36:0; [M-H]-lysoPE 20:4; [M+H]+XANTHINE (M-H)-lysoPE 18:0; [M-H]-PE 36:4; [M+H]+PC 35:1; [M-Ac-H]-PC 40:6; [M-Ac-H]-ALPHA-TOCOPHEROL (M+H)+IS PC 34:0; [M+H]+SM 39:0; [M]+DG 33:2; [M+NH4]+TG 51:2; [M+NH4]+PC 35:4; [M-Ac-H]-LINOLEIC ACID (M-H)-SM 38:1; [M+Na]+HEPTADECANOIC ACID (M-H)-PE 35:0; [M-H]-PC 30:2; [M-Ac-H]-TG 58:9; [M+NH4]+DOCOSAHEXAENOIC ACID (M-H)-plasmenyl-PE 36:3; [M-H]-lysoPC 22:5; [M+H]+PANTOTHENIC ACID (M+H)+PE 33:1; [M-H]-plasmenyl-PE 40:6; [M+H]+PE 38:3; [M+H]+GLUTARIC ACID (M-H)-PI 38:6; [M-H]-PC 34:4; [M+Na]+lysoPC 18:0; [M+Na]+plasmenyl-PE 38:2; [M-H]-P-ACETAMIDOPHENYL BETA-D-GLUCURONIDE (M-H)-plasmenyl-PE 34:2; [M+H]+TG 49:2; [M+NH4]+CE(22:5); [M+NH4]+plasmenyl-PE 36:1; [M+H]+PE 32:1; [M-H]-lysoPE 22:5; [M-H]-TG 62:14; [M+NH4]+PC 40:6; [M+Na]+SM 32:0; [M+Na]+CE(20:4); [M+NH4]+SM 40:0; [M]+MYRISTOLEIC ACID (M-H)-IS PS 34:0; [M+H]+SM 34:2; [M]+PE 40:4; [M-H]-S-ADENOSYL-L-HOMOCYSTEINE (M+H)+plasmenyl-PE 38:6; [M+H]+TG 62:13; [M+NH4]+SM 41:5; [M]+DG 36:0; [M+NH4]+PC 36:1; [M-Ac-H]-FFA(24:2)DECANOYLCARNITINE (*) (M+H)+PC 38:4; [M+H]+3-(4-HYDROXYPHENYL)LACTIC ACID (M-H)-PC 34:4; [M-Ac-H]-PC 36:5; [M+H]+BIS-GAMMA-GLUTAMYLCYSTINE (M-H)-lysoPC 14:0; [M+Na]+SM 39:2; [M]+TG 54:1; [M+Na]+KYNURENINE (M+H)+CerP 34:1; [M-H]-PALMITOLEIC ACID (M-H)-PC 32:3; [M-Ac-H]-TG 51:1; [M+NH4]+IS D31-TAGSM 40:1; [M+Na]+ELAIDIC ACID (M+H)+N-ACETYL-DL-METHIONINE (M+Na)+PIPECOLIC ACID (M+H)+SM 39:1; [M]+GLYCOCHOLIC ACID (M-H)-SM 40:2; [M]+5'-METHYLTHIOADENOSINE (M+H)+TG 56:4; [M+NH4]+3-METHYL-2-OXOPENTANOIC ACID (M-H)-5-HYDROXYINDOLEACETIC ACID (M-H)-SUCCINIC ACID (M-H)-3-(4-HYDROXYPHENYL)LACTIC ACID (M+Na)+TG 48:0; [M+NH4]+BILIVERDIN (M+Na)+3-AMINO-4-HYDROXYBENZOIC ACID (M+H)+PC 38:2; [M-Ac-H]-XANTHOSINE (M-H)-PC 42:11; [M+H]+TRIDECANOIC ACID (M-H)-18:0 LYSO-PE (M+H)+PI 36:2; [M-H]-TG 52:4; [M+NH4]+FFA(24:3)PALMITOLEYLCARNITINE (*) M+PC 33:1; [M-Ac-H]-PE 36:1; [M-H]-plasmenyl-PE 38:4; [M-H]-SM 31:1; [M]+ACETAMINOPHEN (TN TYLENOL) (M+H)+2-HYDROXY-3-METHYLBUTYRIC ACID (M+Na)+PA 34:2; [M-H]-SM 36:2; [M]+lysoPE 18:2; [M-H]-TRYPTOPHAN (M+Na)+GLYCOCHOLIC ACID (M+H)+[-H2O]KYNURENINE (M-H)-FFA(24:0)THEOPHYLLINE (M-H)-PALMITIC ACID (M-H)-TYROSINE (M-H)-PE 38:4; [M-H]-CITRIC ACID (M+Na)+plasmenyl-PE 42:6; [M-H]-PC 36:4; [M+H]+PC 37:4; [M-Ac-H]-2-HYDROXY-3-METHYLBUTYRIC ACID (M-H)-DECENOYLCARNITINE (*) (M+H)+BUTYRYLCARNITINE (*) (M+H)+FFA(20:4) Arachidonic acidLEUKOTRIENE B4 (M+H)+BEHENIC ACID (M-H)-plasmenyl-PE 40:3; [M-H]-lysoPC 19:0; [M+H]+4-QUINOLINECARBOXYLIC ACID #2 (M+H)+SM 41:4; [M]+PE 38:7; [M-H]-HIPPURIC ACID (M-H)-PC 38:6; [M+Na]+FFA(24:1)SM 33:1; [M+Na]+VALINE (M-H)-CE(20:3); [M+NH4]+DG 38:6; [M+NH4]+lysoPE 20:4; [M-H]-PG 36:4; [M-H]-MALIC ACID (M-H)-CE(18:2); [M+NH4]+lysoPC 20:1; [M+H]+3-AMINOISOBUTYRIC ACID (M+H)+[-H2O]lysoPE 22:6; [M+Na]+4-METHYL-2-OXOPENTANOIC ACID (M-H)-PE 36:4; [M-H]-SUBERIC ACID (M-H)-TG 50:0; [M+Na]+DECANOIC ACID (2M+Na)+EPIBRASSINOLIDE [ISTD] (M+Cl)-TG 49:1; [M+NH4]+PI 38:3; [M-H]-PE 33:0; [M-H]-PE 40:6; [M-H]-TAURINE (M-H)-DG 38:4; [M+NH4]+lysoPC 26:0; [M+H]+TG 48:1; [M+NH4]+SM 43:5; [M]+LL-2,6-DIAMINOHEPTANEDIOIC ACID (M+H)+[-H2O]plasmenyl-PE 38:1; [M-H]-plasmenyl-PE 40:6; [M-H]-PC 33:3; [M+H]+ISO-BUTYRYLCARNITINE (*) (M+H)+PC 36:5; [M+Na]+DG 36:4; [M+NH4]+ISOLEUCINE (M+H)+PE 35:2; [M+H]+TG 44:1; [M+NH4]+SM 34:1; [M]+TRYPTOPHAN (M+H)+DEHYDROASCORBIC ACID (M-H)-PC 40:5; [M-Ac-H]-TG 46:1; [M+NH4]+DG 34:4; [M+NH4]+SM 37:1; [M]+TG 40:1; [M+NH4]+TETRADECENOYLCARNITINE (*) M+P-ACETAMIDOPHENYL BETA-D-GLUCURONIDE (M+H)+TG 42:1; [M+NH4]+PE 32:1; [M+H]+ERUCIC ACID (M-H)-lysoPE 22:4; [M-H]-PE 34:1; [M-H]-2-HYDROXYBUTYRIC ACID (M-H)-BILIVERDIN (M-H)-ZEATIN [ISTD] (M+Cl)-lysoPC 20:4; [M+H]+IS CE 17:0; [M+NH4]+SM 33:2; [M]+SM 40:2; [M+Na]+SM 42:1; [M]+PIMELIC ACID (M+Na)+OCTANOYLCARNITINE (*) (M+H)+4-PYRIDOXIC ACID (M+Na)+PC 40:8; [M+Na]+DG 34:2; [M+NH4]+N-(tetracosanoyl)-sphing-4-enine; [M-H]-LIGNOCERIC ACID (M-H)-ADIPIC ACID (M-H)-METHYLMALONIC ACID (M-H)-URIDINE (M+Na)+THEOPHYLLINE (M+Na)+1,3,7-TRIMETHYLURIC ACID (M+H)+PI 36:3; [M-H]-SM 38:5; [M]+TG 48:3; [M+NH4]+lysoPC 22:6; [M+Na]+METHYL JASMONATE (M+H)+lysoPE 18:1; [M+H]+SM 40:5; [M]+PE 34:4; [M-H]-DG 32:2; [M+NH4]+ALPHA-LINOLENIC ACID (M+Na)+TG 58:1; [M+NH4]+DEOXYADENOSINE (M+Cl)-4-HYDROXYBENZOIC ACID (M-H)-MYRISTOYLCARNITINE (*) (M+H)+ISOLEUCINE (M-H)-DG 38:2; [M+NH4]+TRYPTOPHAN (M-H)-TG 56:1; [M+NH4]+DG 36:2; [M+NH4]+FFA(22:2)TG 54:8; [M+NH4]+TG 56:8; [M+NH4]+OLEOYLCARNITINE (*) (M+H)+TG 51:3; [M+NH4]+SM 44:2; [M]+SPHINGOSINE (M+H)+CE(18:0); [M+NH4]+3,4-DIHYDROXYBENZOIC ACID (M-H)-TG 58:8; [M+NH4]+DEOXYCHOLIC ACID (M-H)-3-HYDROXYBENZALDEHYDE (M+H)+[-H2O]PE 34:1; [M+H]+PANTOTHENIC ACID (M+Cl)-TRICOSANOIC ACID (M-H)-SM 35:0; [M]+DEOXYCHOLIC ACID (M+Cl)-16:0 LYSO PC (M+Cl)-GLYCOCHENODEOXYCHOLIC ACID (M+Na)+KYNURENINE (M+Na)+PC 36:6; [M-Ac-H]-18:0 LYSO-PE (M-H)-PE 36:0; [M+H]+FFA(22:3)IBUPROFEN (M-H)-PC 37:6; [M-Ac-H]-NERVONIC ACID (M-H)-PC 30:1; [M-Ac-H]-PC 34:1; [M-Ac-H]-lysoPE 20:3; [M+H]+DG 40:6; [M+NH4]+SM 41:1; [M]+PALMITOYLCARNITINE (M+H)+TG 60:13; [M+NH4]+PHENYLPYRUVIC ACID (M-H)-lysoPC 22:4; [M+H]+PC 36:4; [M-Ac-H]-SM 41:1; [M+Na]+PANTOTHENIC ACID (M-H)-CE(22:6); [M+NH4]+lysoPC 18:2; [M+H]+TYROSINE (M+H)+ADIPIC ACID (M+Na)+plasmenyl-PE 36:3; [M+H]+PROLINE (M+H)+PE 38:4; [M+H]+FFA(22:0)PI 32:0; [M-H]-CIS-11-EICOSENOIC ACID (M-H)-plasmenyl-PE 36:4; [M-H]-PC 40:4; [M+Na]+DODECENOYLCARNITINE (*) M+plasmenyl-PE 34:2; [M-H]-TG 50:1; [M+NH4]+PHENYLALANINE (M+Na)+16:0-18:0 PC (M+H)+PC 34:3; [M-Ac-H]-PE 37:3; [M-H]-TG 54:1; [M+NH4]+3-METHYLXANTHINE (M-H)-SM 32:0; [M]+L-HISTIDINE (M-H)-plasmenyl-PE 36:1; [M-H]-TG 52:1; [M+NH4]+MG 17:0; [M+Li]+SM 30:1; [M+Na]+URIC ACID (M+H)+TG 52:6; [M+Na]+IS Ceramide; [M-H2O]+lysoPC 24:0; [M+H]+CAFFEINE (M+Na)+plasmenyl-PE 34:1; [M+H]+FFA(22:1)PC 36:2; [M-Ac-H]-VALINE (M+H)+SM 44:1; [M]+TG 58:5; [M+NH4]+ACETYLCARNITINE (M+H)+DG 28:0; [M+NH4]+CORTISONE (M+Cl)-PI 38:4; [M-H]-TG 54:5; [M+NH4]+NICOTINAMIDE (M+H)+CL 78:3; [M-2H](2-)4-PYRIDOXIC ACID (M-H)-MYRISTIC ACID (M-H)-N-ACETYL-L-LEUCINE (M+H)+plasmenyl-PE 36:5; [M-H]-TG 50:5; [M+NH4]+LAUROYLCARNITINE (M+H)+HYPOXANTHINE (M-H)-PE 40:7; [M-H]-PE 35:2; [M-H]-ORNITHINE (M+H)+DODECENOYLCARNITINE (*) II M+STEARIC ACID (M-H)-PC 28:0; [M+Na]+TG 54:6; [M+NH4]+PROPIONYLCARNITINE (*) (M+H)+CHOLINE M+SPERMINE (M+H)+PC 38:7; [M-Ac-H]-INOSINE (M+Na)+lysoPC 16:0; [M+Na]+DG 30:0; [M+NH4]+URIC ACID (M-H)-PC 38:6; [M+H]+ISOVALERYLCARNITINE (*) (M+H)+SM 32:2; [M]+lysoPC 24:1; [M+H]+SN-GLYCERO-3-PHOSPHOCHOLINE (M+H)+25-HYDROXYCHOLESTEROL (M+H)+[-H2O]PE 34:3; [M+H]+PC 26:0; [M-Ac-H]-CE(22:4); [M+NH4]+5'-METHYLTHIOADENOSINE (M+Cl)-PE 34:2; [M-H]-PC 36:4; [M+Na]+PI 36:4; [M-H]-PIMELIC ACID (M-H)-IS SM 35:1; [M+H]+TG 58:3; [M+NH4]+CREATINE (M+H)+SM 36:1; [M+Na]+SM 37:2; [M]+plasmenyl-PE 38:5; [M-H]-PE 38:6; [M+H]+TG 54:3; [M+NH4]+PC 40:10; [M+H]+lysoPE 22:6; [M+H]+plasmenyl-PE 38:4; [M+H]+lysoPC 15:0; [M+H]+FFA(20:2)DG 30:1; [M+NH4]+TG 53:3; [M+NH4]+TRANS-ACONITIC ACID (M-H)-SM 30:0; [M]+ADENOSINE 5'-MONOPHOSPHATE (2M-H)+PC 35:3; [M-Ac-H]-TG 58:6; [M+NH4]+DG 35:1; [M+NH4]+TG 60:12; [M+NH4]+EPIBRASSINOLIDE [ISTD] (M+H)+PC 40:8; [M-Ac-H]-TG 58:11; [M+NH4]+PI 34:1; [M-H]-N-ACETYL-L-ALANINE (M-H)-OXALOACETIC ACID (M-H)-[-H2O]AZELAIC ACID (M-H)-PG 36:0; [M-H]-PA 34:1; [M-H]-plasmenyl-PE 32:1; [M-H]-SM 30:1; [M]+PC 35:2; [M-Ac-H]-PC 40:7; [M-Ac-H]-SPERMIDINE (M+H)+CE(18:3); [M+NH4]+DG 38:1; [M+NH4]+lysoPE 20:3; [M-H]-SM 42:1; [M+Na]+DG 35:2; [M+NH4]+HOMOVANILLIC ACID (M+H)+CARNITINE (M+H)+TG 56:9; [M+NH4]+TYROSINE (M+Na)+ARACHIDIC ACID (M-H)-PE 40:6; [M+H]+PE 38:6; [M-H]-DG 40:8; [M+NH4]+CL 74:3; [M-2H](2-)lysoPC 18:3; [M+H]+20:0 LYSO PC (M+H)+IS DG 34:1; [M+NH4]+PC 39:4; [M-Ac-H]-FFA(20:0)RETINOIC ACID (M-H)-PI 32:1; [M-H]-PE 35:1; [M+H]+plasmenyl-PE 36:4; [M+H]+MANDELIC ACID (M-H)-PE 37:2; [M-H]-lysoPC 18:1; [M+Na]+SM 35:2; [M+Na]+1,3-DIMETHYLURIC ACID (M-H)-plasmenyl-PE 34:1; [M-H]-PC 32:1; [M+Na]+SM 36:1; [M]+PC 40:5; [M+Na]+3-METHYLXANTHINE (M+H)+TG 50:3; [M+NH4]+TRYPTOPHAN (2M-H)-DESMOSTEROL (M+H)+[-H2O]PE 35:3; [M-H]-SPHINGANINE (M+H)+OLEOYL-GLYCEROL (M+Na)+PC 30:0; [M+Na]+SM 43:4; [M]+TG 53:2; [M+NH4]+PC 28:0; [M-Ac-H]-TG 60:11; [M+NH4]+FFA(20:1)PA 34:0; [M+Na]+OLEOYL-GLYCEROL (M+H)+DG 35:3; [M+NH4]+SM 43:1; [M]+24:0 SM (D18:1/24:0) (M+Cl)-PE 38:1; [M-H]-IS MG 17:0; [M+NH4]+SEROTONIN (M+Na)+DG 34:0; [M+NH4]+lysoPC 14:0; [M+H]+PE 39:6; [M-H]-PE 36:2; [M-H]-TRANS-CYCLOHEXANE-1,2-DIOL (M+Na)+FFA(18:2)lysoPE 18:2; [M+H]+TG 58:10; [M+NH4]+N-ACETYL-L-LEUCINE (M-H)-PC 38:4; [M-Ac-H]-HYPOXANTHINE (M+H)+N-(hexadecanoyl)-sphing-4-enine; [M-H]-TG 60:10; [M+NH4]+ASCORBIC ACID (M+H)+[-H2O]lysoPC 22:5; [M+Na]+SM 43:2; [M]+TG 53:1; [M+NH4]+PC 30:0; [M-Ac-H]-PC 36:3; [M-Ac-H]-HEXANOYLCARNITINE (*) M+plasmenyl-PE 40:4; [M-H]-LYSINE (M+H)+ACETAMINOPHEN (TN TYLENOL) (M+Na)+DG 36:5; [M+NH4]+PC 34:2; [M-Ac-H]-THEOBROMINE (M+H)+TG 50:4; [M+NH4]+PE 37:6; [M+H]+TG 54:4; [M+NH4]+TG 52:1; [M+Na]+PE 34:3; [M-H]-TG 46:0; [M+NH4]+PC 32:1; [M-Ac-H]-PE 34:2; [M+H]+CREATININE (M+H)+lipids, secondary metabolites, metabolite, primary metabolites, Lipid., metabolitesLipid., LipidfalsePrenatal exposures and Metabolite and Lipid ProfilesST0005239606